Lacamas Laboratories
Custom contract manufacturer of pharmaceutical intermediates and fine chemicals based in Oregon. Provides pilot-to-ton scale manufacturing, process development and scale-up, specialized handling of hazardous and air-/moisture-sensitive chemistries, analytical quality control, and international logistics. Maintains ISO 9001-certified quality systems and facilities with large reactor capacity and specialized separation and hydrogenation equipment.
Industries
Nr. of Employees
small (1-50)
Lacamas Laboratories
3625 N. Suttle Road, Portland, OR 97217; 1290 Industrial Way SW, Albany, OR 97322; Mail: P.O. Box 17659, Portland, OR 97217
Products
Di-tert-butyl dicarbonate (DIBOC)
Chemical reagent used for Boc protection of amines; offered at kilogram to ton scale with purity and identity testing.
Diisopropylzinc solution (in xylene)
Organometallic reagent manufactured at ton scale as a solution in xylene.
Isopropylmagnesium chloride solution, 2.0 M in THF
Grignard reagent solution provided with specified molarity for synthetic applications.
Ethylmagnesium bromide solution, ~1.4 M in THF:toluene (1:3)
Grignard reagent solution with specified active molarity and base molarity.
Diethyl p-toluenesulfonyloxymethylphosphonate
Specialty phosphonate reagent supplied with analytical specifications (purity, water content).
Di-tert-butyl dicarbonate (DIBOC)
Chemical reagent used for Boc protection of amines; offered at kilogram to ton scale with purity and identity testing.
Diisopropylzinc solution (in xylene)
Organometallic reagent manufactured at ton scale as a solution in xylene.
Isopropylmagnesium chloride solution, 2.0 M in THF
Grignard reagent solution provided with specified molarity for synthetic applications.
Ethylmagnesium bromide solution, ~1.4 M in THF:toluene (1:3)
Grignard reagent solution with specified active molarity and base molarity.
Diethyl p-toluenesulfonyloxymethylphosphonate
Specialty phosphonate reagent supplied with analytical specifications (purity, water content).
Services
Development and manufacture of pharmaceutical intermediates and specialty chemicals from pilot to ton-scale production.
Laboratory and pilot development, optimization and transfer of synthetic routes for safe, robust and economic large-scale manufacture.
Product identity, purity and stability testing using HPLC, GC, GC-MS, NMR, FT-IR, KF titration and stability chambers supporting release testing and QC.
Packaging and shipping of hazardous and temperature-sensitive chemicals by sea, air and rail with cold-chain options.
Development and manufacture of pharmaceutical intermediates and specialty chemicals from pilot to ton-scale production.
Laboratory and pilot development, optimization and transfer of synthetic routes for safe, robust and economic large-scale manufacture.
Product identity, purity and stability testing using HPLC, GC, GC-MS, NMR, FT-IR, KF titration and stability chambers supporting release testing and QC.
Packaging and shipping of hazardous and temperature-sensitive chemicals by sea, air and rail with cold-chain options.
Expertise Areas
- Custom contract manufacturing of pharmaceutical intermediates
- Pilot-to-commercial scale process development
- Large-scale organometallic reagent production
- Hazardous chemistry handling and corrosion-resistant processing
Key Technologies
- Glass-lined and stainless steel reactors (up to 2000 gallon)
- Hastelloy reactors
- Thin-film evaporators
- Multi-plate fractionating distillation
News & Updates
Department of Defense program awarded funds to establish domestic manufacturing capacity for critical chemicals; Lacamas Laboratories is listed among awardees for production of several defense-related chemicals.
Press release announcing award of an approximately $86 million Department of Defense contract to develop and construct manufacturing capability for critical defense materials at Lacamas Laboratories' Portland facility.
Department of Defense program awarded funds to establish domestic manufacturing capacity for critical chemicals; Lacamas Laboratories is listed among awardees for production of several defense-related chemicals.
Press release announcing award of an approximately $86 million Department of Defense contract to develop and construct manufacturing capability for critical defense materials at Lacamas Laboratories' Portland facility.